Regulation of insulin receptor activity of human erythrocyte membrane by prostaglandin E1
- PMID: 3516223
- DOI: 10.1016/0005-2736(86)90132-x
Regulation of insulin receptor activity of human erythrocyte membrane by prostaglandin E1
Abstract
Incubation of human erythrocyte membrane with low concentration of prostaglandin E1 or prostacyclin increased the binding of 125I-labeled insulin to the membrane. The binding of the radioiodinated hormone was maximally stimulated at 3 nM prostaglandin E1 and the use of higher concentrations (above 8 nM) of the autacoid tended to reverse its own effect at lower concentrations. While prostaglandins A1, A2, B1, B2, D2, F1 alpha, F2 alpha or 6-keto-prostaglandin F1 alpha had no effect on the binding of insulin to the erythrocyte membrane, prostaglandin E2 at similar concentrations decreased the binding of the hormone. The effect of prostaglandin E1 on the increased binding of the insulin was found to be reversible and depended on the occupancy of the autacoid molecules on the membrane and showed positive cooperativity. Scatchard analysis of the binding of 125I-labeled insulin to the erythrocyte ghosts indicated that in the presence of the autacoid, the binding capacity of the insulin receptor increased 2-fold (from 207 to 424 fmol/mg protein) without any change in the ghosts affinity for the ligand (Kd 2.4 X 10(-9) versus 2.49 X 10(-9) M). As a consequence of increased binding of insulin to the erythrocyte membrane in the presence of prostaglandin E1 (3.0 nM), the optimal concentration of the peptide hormone for the maximal reduction of the membrane microviscosity decreased from approx. 1.6 to approx. 0.4 nM. Addition of prostaglandin E1 alone at the above concentration to the assay mixture had no effect on the membrane microviscosity.
Similar articles
-
Binding of prostaglandin E1 to human erythrocyte membrane.Biochim Biophys Acta. 1985 Feb 14;812(3):671-8. doi: 10.1016/0005-2736(85)90260-3. Biochim Biophys Acta. 1985. PMID: 2982399
-
Prostaglandin-E1-binding sites in rabbit erythrocyte membranes.Eur J Biochem. 1993 May 1;213(3):1167-73. doi: 10.1111/j.1432-1033.1993.tb17867.x. Eur J Biochem. 1993. PMID: 8504810
-
Inhibition of prostaglandin E1-induced activation of adenylate cyclase in human blood platelet membrane.Biochim Biophys Acta. 1988 Oct 28;972(1):45-53. doi: 10.1016/0167-4889(88)90101-2. Biochim Biophys Acta. 1988. PMID: 2902882
-
Interaction of receptors for prostaglandin E1/prostacyclin and insulin in human erythrocytes and platelets.Life Sci. 1991;49(16):1129-39. doi: 10.1016/0024-3205(91)90560-x. Life Sci. 1991. PMID: 1654491 Review.
-
Role of insulin receptors in the expression of prostaglandin E1 binding activity in platelets.Adv Exp Med Biol. 1990;281:271-6. doi: 10.1007/978-1-4615-3806-6_28. Adv Exp Med Biol. 1990. PMID: 1966355 Review. No abstract available.
Cited by
-
Changes in erythrocyte membrane fluidity by endotoxin in rats.J Anesth. 1992 Apr;6(2):145-52. doi: 10.1007/s0054020060145. J Anesth. 1992. PMID: 15278558
-
Sustained caloric restriction potentiates insulin action by activating prostacyclin synthase.Obesity (Silver Spring). 2024 Dec;32(12):2286-2298. doi: 10.1002/oby.24150. Epub 2024 Oct 17. Obesity (Silver Spring). 2024. PMID: 39420421 Free PMC article.
-
Relationship between mouse liver delta 9 desaturase activity and plasma lipids.Lipids. 1993 Apr;28(4):285-90. doi: 10.1007/BF02536312. Lipids. 1993. PMID: 8487620
-
Impaired binding of insulin to erythrocyte membrane receptor and the activation of nitric oxide synthase by the hormone in human breast cancer.J Cancer Res Clin Oncol. 2004 May;130(5):294-300. doi: 10.1007/s00432-003-0532-9. Epub 2004 Feb 19. J Cancer Res Clin Oncol. 2004. PMID: 14986111 Free PMC article.
-
A study of the capacity of various eicosanoids to stimulate skeletal muscle formation in chicken embryos.J Anat. 1991 Feb;174:115-24. J Anat. 1991. PMID: 1903374 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous